Patents by Inventor Igor Koman

Igor Koman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260117192
    Abstract: Three-dimensional tumor avatars comprising an artificial scaffold, tumor cells, tumor associated endothelial cells and tumor associated fibroblast cells are provided. Kits comprising the 3D tumor avatars, methods of producing the 3D tumor avatars and methods of using the 3D tumor avatars are also provided.
    Type: Application
    Filed: December 26, 2025
    Publication date: April 30, 2026
    Inventors: Gabriela ROZIC, Igor KOMAN
  • Publication number: 20240390396
    Abstract: The present invention discloses a pharmaceutical composition including a cannabinoid and a transient receptor potential cation channel (TRP) ligand, and methods of using same, such as for treating a subject afflicted with a cell proliferation related disease, or alleviating a symptom associated therewith.
    Type: Application
    Filed: August 29, 2022
    Publication date: November 28, 2024
    Inventors: Noa DAVIS, Igor KOMAN, Natalya M. KOGAN
  • Patent number: 12115207
    Abstract: A method of treating an inflammatory disease or disorder is disclosed. The method comprises administering to the subject a therapeutically effective amount of a peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 11-15. The inflammatory disease is not cancer, osteoporosis, rheumatic arthritis, osteoarthritis or angiogenesis-related eye disease.
    Type: Grant
    Filed: October 13, 2020
    Date of Patent: October 15, 2024
    Assignees: Ariel Scientific Innovations Ltd., Health Research, Inc.
    Inventors: Andrei Gudkov, Elimelech Nesher, Albert Pinhasov, Igor Koman, Yekaterina Leonova
  • Publication number: 20210023164
    Abstract: A method of treating an inflammatory disease or disorder is disclosed. The method comprises administering to the subject a therapeutically effective amount of a peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 11-15. The inflammatory disease is not cancer, osteoporosis, rheumatic arthritis, osteoarthritis or angiogenesis-related eye disease.
    Type: Application
    Filed: October 13, 2020
    Publication date: January 28, 2021
    Applicants: Ariel Scientific Innovations Ltd., Health Research, Inc.
    Inventors: Andrei GUDKOV, Elimelech NESHER, Albert PINHASOV, Igor KOMAN, Yekaterina LEONOVA
  • Publication number: 20190351202
    Abstract: The present invention discloses a capsule configured for controllably remaining within a patient's body for a certain period of time as well as a system comprising the capsule thereof. The invention also discloses a capsule being configured and operable for electrical stimulation, as well as a system comprising the capsule thereof.
    Type: Application
    Filed: January 11, 2018
    Publication date: November 21, 2019
    Inventors: Alexander Melamud, Boris Voznesensky, Rita Zucker, Igor Koman